GlassScriptPhysician profile
Azhil Durairaj
NPI 1609826973
$38,861.22
in general payments reported to CMS, 2019-2025
55 companies · $5,836 in 2025
The $5,836 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,289 · 2020: $2,455 · 2021: $5,022 · 2022: $6,729 · 2023: $6,125 · 2024: $6,404 · 2025: $5,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $3,831 · Entertainment: $48.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,486.20 |
| Travel and Lodging | $3,830.59 |
| Entertainment | $48.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17,322.33 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Konect Resilia |
| Abbott Laboratories | $5,446.67 | 2019-2025 | Xience V, Optis, Cardiomems |
| Boston Scientific Corporation | $3,257.96 | 2019-2025 | Watchman Flx, Rotapro, Sentinel |
| Novartis Pharmaceuticals Corporation | $1,371.29 | 2019-2025 | |
| Amgen INC. | $1,322.32 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,142.96 | 2019-2025 | |
| Shockwave Medical, INC | $1,057.35 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merz North America, INC. | $774.33 | 2024-2025 | |
| Abiomed | $769.96 | 2019-2024 | Impella |
| Cardiva Medical, INC. | $657.43 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $508.92 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $350.77 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.20 | 2019-2024 | Jardiance |
| Medtronic, INC. | $307.92 | 2024-2025 | Symplicity G3, Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $306.80 | 2021-2025 | Farxiga, Wainua |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $292.72 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $286.28 | 2020-2024 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $281.24 | 2021-2022 | |
| Galderma Laboratories, L.P. | $237.14 | 2019-2023 | |
| Penumbra, INC. | $234.54 | 2022 | |
| Impulse Dynamics (USA) INC. | $227.98 | 2022-2025 | Optimizer |
| Inari Medical, INC. | $185.57 | 2022 | |
| Kestra Medical Technology Services, INC. | $181.31 | 2022-2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $157.37 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $153.86 | 2021-2024 | Verquvo |
| Cordis US Corp. | $146.57 | 2025 | Mynx Control Venous, Mynx Control |
| Csl Behring | $124.98 | 2024 | Kcentra |
| Opsens INC. | $120.98 | 2023 | Optowire |
| Bayer Healthcare Pharmaceuticals INC. | $118.71 | 2021-2024 | |
| Novo Nordisk INC | $107.15 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $106.49 | 2019-2023 | |
| Cleerly, INC. | $100.92 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic Vascular, INC. | $100.12 | 2020 | |
| W. L. Gore & Associates, INC. | $96.00 | 2023-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Cardioform Septal Occluder |
| Heartflow, INC. | $75.68 | 2022 | |
| Alnylam Pharmaceuticals INC. | $71.66 | 2024-2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $50.36 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $46.80 | 2019-2020 | |
| United Therapeutics Corporation | $45.98 | 2022-2025 | Orenitram |
| Gilead Sciences, INC. | $39.76 | 2019 | |
| Endotronix, INC. | $35.34 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Kiniksa Pharmaceuticals, LTD. | $35.01 | 2021 | |
| Acist Medical Systems, INC. | $35.00 | 2021 | |
| Akcea Therapeutics, INC. | $32.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.84 | 2019-2020 | |
| Inspire Medical Systems, INC. | $24.35 | 2025 | Inspire |
| Cvrx, INC. | $22.06 | 2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $20.92 | 2023 | Zio Xt Patch |
| Celgene Corporation | $20.49 | 2024 | Camzyos |
| Astellas Pharma US INC | $20.30 | 2022 | |
| Terumo Medical Corporation | $18.73 | 2019 | |
| Atricure, INC. | $15.66 | 2021 | |
| Philips North America LLC | $14.77 | 2020 | |
| Tactile Systems Technology INC | $14.17 | 2020 | |
| Siemens Medical Solutions USA, INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azhil Durairaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.